Nateglinide
- Product NDC
- 52536-063
- 11-digit product format
- 525360063
- Labeler code
- 52536
- Product ID
- 52536-063_1e45811e-8694-4456-9270-388a115dcb6c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nateglinide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Wilshire Pharmaceuticals, Inc.
- Application
- ANDA205544
- Marketing category
- ANDA
- Marketing start
- 2019-04-20
- Marketing end
- 0000-00-00
- Substance
- NATEGLINIDE
- Active strength
- 60 mg/1
- Pharmacologic classes
- Glinide [EPC],Potassium Channel Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 52536-063-10 | 2021-03-29 | C162847 | 48780-1 | ba0f9c33-42e7-a910-e053-dadaa90a0b85 | 72b62a48-7fe4-4069-b642-1ab73bb8d06c |
| 52536-063-50 | 2021-03-29 | C162847 | 48780-1 | ba0f9c33-42e7-a910-e053-dadaa90a0b85 | 72b62a48-7fe4-4069-b642-1ab73bb8d06c |
| 52536-063-10 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-42e7-a910-e053-dadaa90a0b85 | 72b62a48-7fe4-4069-b642-1ab73bb8d06c |
| 52536-063-50 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-42e7-a910-e053-dadaa90a0b85 | 72b62a48-7fe4-4069-b642-1ab73bb8d06c |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 52536-063-10 | EA - Each | 52536-063 | 09fe95bd-068b-46ac-b2cb-c8171bb71794 | 1 | 2019-07-02 |